| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 0.11% | -83.33% | 113.75% | 101/138 | 0.51% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | -0.8% | -105.13% | -2100% | 108/138 | 1.91% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | 0.04% | -88.24% | 102.58% | 104/138 | 1.06% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | -1.55% | 14.36% | -334.85% | 101/138 | 3.05% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 0.66% | -7.04% | 269.23% | 98/138 | 4.75% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | -0.39% | -129.41% | -214.71% | 108/138 | 2.98% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 0.34% | -17.07% | 118.78% | 95/138 | 1.65% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | -1.81% | -503.33% | -354.93% | 108/138 | 4.92% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 0.71% | -69.92% | 517.65% | 104/138 | 5.8% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | -0.17% | -116.5% | -141.46% | 113/138 | 3.8% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 0.41% | -76.7% | 236.67% | 101/138 | 2.28% | 安杰思 | 8.56% | 行业排名> |
| 2022-12-31 | -0.3% | -101.45% | -112.71% | 112/138 | 12.93% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 2.36% | -88.95% | 129.13% | 101/138 | 12.7% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 1.03% | -92.43% | -41.48% | 106/138 | 9.24% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 1.76% | 2% | -91.49% | 72/138 | 6.21% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 20.69% | 246.57% | -3.14% | 37/138 | 17.28% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 21.36% | 2% | 57.06% | 20/138 | 15.82% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 13.6% | 53.5% | 127.81% | 30/138 | 11.46% | 热景生物 | 99.09% | 行业排名> |
| 2020-12-31 | 5.97% | -48.36% | -32.62% | 103/138 | 25.47% | 热景生物 | 57.63% | 行业排名> |
| 2020-06-30 | 8.86% | 2% | -23.36% | 48/138 | 15.03% | 中红医疗 | 168% | 行业排名> |
| 2019-12-31 | 11.56% | 42.54% | 42.54% | 70/138 | 14.24% | 圣湘生物 | 112.46% | 行业排名> |
| 2018-12-31 | 8.11% | 11.71% | 11.71% | 78/138 | 12.87% | 博拓生物 | 108.13% | 行业排名> |
| 2017-12-31 | 7.26% | 2% | 2% | 73/138 | 13.76% | 圣湘生物 | 29.33% | 行业排名> |

微信公众号
证券之星APP


